Capital One National Association’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-5,896
| Closed | -$342K | – | 516 |
|
2017
Q3 | $342K | Buy |
5,896
+134
| +2% | +$7.77K | 0.02% | 417 |
|
2017
Q2 | $284K | Sell |
5,762
-24
| -0.4% | -$1.18K | 0.02% | 439 |
|
2017
Q1 | $251K | Buy |
5,786
+483
| +9% | +$21K | 0.02% | 461 |
|
2016
Q4 | $260K | Sell |
5,303
-142
| -3% | -$6.96K | 0.02% | 442 |
|
2016
Q3 | $261K | Buy |
5,445
+282
| +5% | +$13.5K | 0.02% | 443 |
|
2016
Q2 | $277K | Buy |
+5,163
| New | +$277K | 0.02% | 435 |
|
2015
Q2 | – | Sell |
-7,532
| Closed | -$310K | – | 535 |
|
2015
Q1 | $310K | Buy |
7,532
+2,304
| +44% | +$94.8K | 0.03% | 453 |
|
2014
Q4 | $213K | Buy |
+5,228
| New | +$213K | 0.02% | 505 |
|
2014
Q3 | – | Sell |
-5,604
| Closed | -$260K | – | 526 |
|
2014
Q2 | $260K | Buy |
5,604
+5
| +0.1% | +$232 | 0.02% | 462 |
|
2014
Q1 | $230K | Buy |
+5,599
| New | +$230K | 0.02% | 498 |
|